Attached files
| file | filename |
|---|---|
| 10-Q - Q3 10Q - Obagi Medical Products, Inc. | form10q.htm |
| EX-10.57 - TRIAX AGREEMENT - REDACTED VERSION - Obagi Medical Products, Inc. | exhibit10_57.htm |
| EX-10.58 - CELLOGIQUE AMMENDMENT NO 2 - REDACTED VERSION - Obagi Medical Products, Inc. | exhibit10_58.htm |
| EX-10.48 - ROHTO AMMENDMENT - REDACTED VERSION - Obagi Medical Products, Inc. | exhibit10_48.htm |
| EX-31.2 - 302 CERTIFICATION - Obagi Medical Products, Inc. | exhibit31_22009q3.htm |
| EX-32.1 - 906 CERTIFICATION - Obagi Medical Products, Inc. | exhibit32_12009q3.htm |
| EX-31.1 - 302 CERTIFICATION - Obagi Medical Products, Inc. | exhibit31_12009q3.htm |
Exhibit 32.2
CERTIFICATION
OF THE CHIEF FINANCIAL OFFICER
PURSUANT
TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report on Form 10-Q of Obagi Medical
Products, Inc. (the "Company") for the three months ended September 30,
2009 as filed with the Securities and Exchange Commission on the date hereof
(the "Report"), I, Preston S. Romm, Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results
of operations of the Company.
|
Date:
November 6, 2009
|
By:
|
/s/ PRESTON
S. ROMM
|
|
|
Preston
S. Romm
|
|||
|
Chief
Financial Officer
|
|||
|
(Principal
Financial Officer)
|
|||